PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Unprecedented progress in tackling smoking during pregnancy threatened by NHS cuts, experts warn

Peer reviewed - opinion - humans

2025-05-12
(Press-News.org)

Unprecedented progress in reducing the number of women smoking during pregnancy in England could be put at risk by NHS funding cuts, according to a UEA addiction expert.

A new BMJ article, co-authored by Prof Caitlin Notley from UEA’s Norwich Medical School, reveals that the proportion of women smoking during pregnancy in England has almost halved in the last decade.

Most of the decline happened in the last five years thanks to the introduction of dedicated stop smoking advisers in NHS maternity services since 2020.

But the team fear that the reduction could be threatened by cost-cutting exercises.

And they are calling for continued investment to give every child a smokefree start in life.

The article has been written by members of the Smoking in Pregnancy Challenge Group - a coalition of organisations committed to reducing rates of smoking in pregnancy.

It shows how the amount of women smoking during pregnancy dropped from 11.7 per cent in 2014/15 to 5.9 per cent as of Q3 2024/25.

Prof Notley, professor of Addiction Sciences at UEA, said: “The progress on reducing rates of smoking in pregnancy has accelerated in recent years, thanks to the focused efforts of all healthcare professionals involved in the pregnancy care pathway.

“However, there remain significant inequalities, as rates of smoking remain higher in deprived areas - suggesting that we need innovative targeted approaches for those who really struggle to quit.”

The authors say that cuts to integrated care boards (ICB) budgets and the loss of ringfenced funding for NHS tobacco treatment services could threaten the success.

Stop smoking support in some hospitals and mental health services has already been cut, according to the group, with further cuts expected.

The Smoking in Pregnancy Challenge Group is a partnership between the Royal College of Midwives, the Royal College of Obstetricians and Gynaecologists and the Royal College of Paediatrics and Child Health, the voluntary sector and academia.

Prof Linda Bauld, director of the SPECTRUM Research Consortium, co-chair of the Smoking in Pregnancy Challenge Group and co-author of the BMJ article said: “The evidence is clear that stop smoking support for pregnant women has played a vital role in reducing rates of maternal smoking and saving babies’ lives. Without continued investment in these services there is a real risk that this decline could stall, or even start to reverse, with tragic consequences for parents and families.” 

Dr Clea Harmer, chief executive of Sands and co-chair of the Smoking in Pregnancy Challenge Group, said: “As the government sets its sights on a smokefree generation, now is not the time to be cutting investment in these services. Instead, they should be going further and faster to ensure every child has a smokefree start in life.”

John Waldron, policy and public affairs manager at Action on Smoking and Health and co-author of the BMJ article said: “The 2024 Labour manifesto committed to ensuring that all hospitals integrate smoking cessation support into routine care. The government must deliver on this commitment by protecting funding for these lifesaving services.”

‘NHS Cuts Could Spark Surge in Smoking During Pregnancy, Experts Warn’ is published in the British Medical Journal (BMJ).

ENDS

END


ELSE PRESS RELEASES FROM THIS DATE:

Top scientific research recognized at ACC Asia Conference

2025-05-12
The American College of Cardiology has recognized three outstanding abstract presentations as Abstract Award winners at the ACC Asia 2025 Together with SCS 36th Annual Scientific Meeting on May 9-11 in Singapore. The conference brings together leading experts and cardiovascular clinicians from across Asia to examine emerging trends and evidence-based strategies in the prevention and management of patients with heart disease. This year’s winners were selected for their high-quality research that furthers the ACC’s mission to transform cardiovascular care and improve heart health. This year’s Abstract Award winners are: Yanji Qu, MD, PhD - Guangdong ...

GLP-1 drugs are helpful for children who are living with severe obesity, data from Swedish clinic indicates

2025-05-12
Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs form part of their treatment, new research being presented at year’s European Congress on Obesity (ECO 2025) suggests. Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of a hormone called GLP-1 to reduce appetite and feelings of hunger, slow the release of food from the stomach and increase feelings of fullness after eating. “GLP-1 drugs are increasingly used to treat obesity in adults,” ...

Popular weight-loss drugs following bariatric surgery may offer additional cardiovascular benefits

2025-05-12
Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and diabetes following bariatric surgery who did not achieve sufficient weight loss and diabetes control, according to new research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May). The observational, real-life retrospective cohort study found that in adults with obesity and type 2 diabetes but no prior heart disease, glucagon-like peptide-1 receptor agonists (GLP-1RAs) ...

Patients of an online obesity clinic achieved the same weight loss as those in clinical trials of semaglutide – but with much lower doses of the drug

2025-05-12
New research being presented at this year’s European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials – but with less than half the medication. The study is to be published in the journal The Lancet Digital Health. Patients who followed the programme had an average weight loss of 16.7% (16.8kg/2st 9lb) after 64 weeks, which is on par with that seen in randomised controlled trials of the same drug, semaglutide, a glucagon-like peptide-1 ...

Protein bars enriched with collagen have potential as a weight-loss aid, Spanish study finds

2025-05-12
Research being presented at this year’s European Congress on Obesity (ECO 2025) and published in the journal Nutrients indicates that collagen could be a safe and effective weight-loss supplement. Individuals with overweight and obesity who ate protein bars enriched with collagen, a protein that is found in connective tissue, lost twice as much weight as a control group who did not have the supplement.  They also experienced greater decreases in blood pressure and waist circumference and saw their liver health improve more.  They may also have ...

Semaglutide may provide early protection against heart disease in high-risk patients—even before clinically meaningful weight loss and prior to the full target dose

2025-05-12
Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes, according to a secondary analysis of the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial from the same international author team being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May).   “These results highlight semaglutide’s early action on decreasing major cardiovascular events, with significant benefits already evident ...

Civil defense units must invest in professionalization and own resources to face climate risks

2025-05-12
As the effects of climate change intensify in urban areas, it is essential to strengthen the organizational capacity of civil defense units to implement disaster risk management, including prevention and mitigation. To contribute to this debate, a study conducted by researchers from the Brazilian National Center for Monitoring and Early Warning of Natural Disasters (CEMADEN) proposes a public policy focused on five fronts. These are: 1) professionalization of managers and officials in the area; 2) development of capacities adapted to regional specificities and to each biome; 3) allocation of their own budget to municipalities; 4) continuous ...

Flamingos create water tornados to trap their prey

2025-05-12
Flamingos standing serenely in a shallow alkaline lake with heads submerged may seem to be placidly feeding, but there's a lot going on under the surface. Through studies of Chilean flamingos in the Nashville Zoo and analysis of 3D printed models of their feet and L-shaped bills, researchers have documented how the birds use their feet, heads and beaks to create a storm of swirling tornados, or vortices, in the water to efficiently concentrate and slurp up their prey. "Flamingos are actually predators, they are actively looking for animals that are moving in the water, and the problem they face is how to concentrate these animals, to pull them together and ...

FFAR taps Danforth Center plant scientists for crop research to preserve soil and water health

2025-05-12
ST. LOUIS, MO, May 12, 2025 — The Foundation for Food & Agriculture Research (FFAR) and matching funders today awarded two Seeding Solutions grants totaling over $5 million to the Donald Danforth Plant Science Center (Danforth Center) for crop development research. FFAR, the Danforth Center, Kansas State University, The Land Institute, the Perennial Agriculture Project and Saint Louis University provided $2,926,098 to a project accelerating the domestication of perennial crops, which are planted once and ...

Research spotlight: ‘Cell line atlas’ provides a crucial resource for developing therapies for biliary tract cancer

2025-05-12
How would you summarize your study for a lay audience?  Advanced biliary tract cancer (BTC) includes cholangiocarcinoma, gallbladder carcinoma, and ampullary carcinoma. BTC is a rare and aggressive group of cancers, carrying one of the worst prognoses in all of oncology. Only about 10% of patients survive beyond five years.  Although these cancers differ significantly depending on where they arise within the biliary system—a network of ducts that transports bile to aid digestion—most patients receive the same standard treatment: a combination ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Unprecedented progress in tackling smoking during pregnancy threatened by NHS cuts, experts warn
Peer reviewed - opinion - humans